Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Stephen Djedjos
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia
Cardiovascular Drugs and Therapy
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Related publications
Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials
Journal of Pharmacy and Pharmaceutical Sciences
Medicine
Pharmacology
Pharmaceutical Science
Efficacy and Safety of Monascus Purpureus Went Rice in Subjects With Hyperlipidemia
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Questioning the Safety and Benefits of Evolocumab
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Clinical Utility of Evolocumab in the Management of Hyperlipidemia: Patient Selection and Follow-Up
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Non-Interventional Study of Efficacy and Safety of Rosuvastatin Therapy and Introduction of Additional Doses to Clinical Practice in Patients With Hyperlipidemia
Cardiologia Croatica
Cardiovascular Medicine
Cardiology
Questioning the Safety and Benefits of Evolocumab – Authors' Reply
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy of Evolocumab in Monogenic Versus Polygenic Hypercholesterolemia
CJC Open
Cardiovascular Medicine
Cardiology
Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN)
Clinical Journal of Pain
Neurology
Anesthesiology
Pain Medicine
